Chet Billingsley is the Chairman, CEO, and founder of Mentor Capital, Inc. He is a native of Minnesota who received a congressional appointment and did his undergraduate work at West Point. Later, he went to graduate school at Harvard University where he received a Master’s Degree in Applied Physics with concurrent study at Harvard Business School, and at MIT studying proton radiology as applied to difficult to treat cancers in conjunction with Mass General Hospital.
Mr. Billingsley spent the major portion of his early career in technical sectors of General Electric in project, turn-around, and international management positions. In 1985, he formed Tech Start, the predecessor to Mentor Capital, in the heart of Silicon Valley. He has held the general manager or president position since that time.
In 1995, he took the firm public and has had lead responsibility in the Tech III Partners, Cambridge Equity Partners, and Mentor Investors I, LP financial partnerships. He has directed the successful acquisition or investment in thirty-eight operating portfolio businesses or entities.
Mr. Billingsley is a conservative, 62 year old, non-using businessman. In August 2013, he led the surprising but science-based decision to take Mentor Capital into the medical marijuana space. The goal was to pursue an alternative approach to fighting cancer, calming seizures, reducing ocular pressure, and blunting pain, while seeking significant shareholder returns.
As a public company pioneer in the legal cannabis space, Mr. Billingsley became a founding director and officer of the board of directors of the Nevada Cannabis Industry Association in November 2013.